Clinical trials talk with Tom Frazier from Autism Speaks

This week, a special surprise:  a conversation with Dr. Thomas Frazier, Chief Science Officer of Autism Speaks, on what is needed for better clinical trials for drug treatments for ASD, and what they are going to be doing to help move the science along.  Of course, the conversation hit on other topics, like disclosure of a diagnosis, sex differences, and some of the newest more exciting findings in autism research.

One Reply to “Clinical trials talk with Tom Frazier from Autism Speaks”

  1. Dear Dr. Tom Frazier: Hi! This is Vj, Mom to a son w Autistic Disorder. My son is 27 yrs old and is non-verbal mostly.

    My question:
    Do you have a clinical trial to try “Perispinal Etanercept” injections on people w ASD?

    it has shown great improvements in adults w memory loss due to Alzheimer’s..

    Please reply w your opinion on it.

    Thank you.

    W regards,
    Vj

Leave a Reply

Your email address will not be published. Required fields are marked *